These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 32844199)
1. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease. Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199 [TBL] [Abstract][Full Text] [Related]
2. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131 [TBL] [Abstract][Full Text] [Related]
3. Dysbiosis of gut microbiota in a selected population of Parkinson's patients. Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953 [TBL] [Abstract][Full Text] [Related]
5. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome. Boktor JC; Sharon G; Verhagen Metman LA; Hall DA; Engen PA; Zreloff Z; Hakim DJ; Bostick JW; Ousey J; Lange D; Humphrey G; Ackermann G; Carlin M; Knight R; Keshavarzian A; Mazmanian SK Mov Disord; 2023 Mar; 38(3):399-409. PubMed ID: 36691982 [TBL] [Abstract][Full Text] [Related]
6. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Wen C; Zheng Z; Shao T; Liu L; Xie Z; Le Chatelier E; He Z; Zhong W; Fan Y; Zhang L; Li H; Wu C; Hu C; Xu Q; Zhou J; Cai S; Wang D; Huang Y; Breban M; Qin N; Ehrlich SD Genome Biol; 2017 Jul; 18(1):142. PubMed ID: 28750650 [TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358 [TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease. Rosario D; Bidkhori G; Lee S; Bedarf J; Hildebrand F; Le Chatelier E; Uhlen M; Ehrlich SD; Proctor G; Wüllner U; Mardinoglu A; Shoaie S Cell Rep; 2021 Mar; 34(9):108807. PubMed ID: 33657381 [TBL] [Abstract][Full Text] [Related]
10. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641 [TBL] [Abstract][Full Text] [Related]
11. Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. Palacios N; Wilkinson J; Bjornevik K; Schwarzschild MA; McIver L; Ascherio A; Huttenhower C Ann Neurol; 2023 Sep; 94(3):486-501. PubMed ID: 37314861 [TBL] [Abstract][Full Text] [Related]
12. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease. Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease. Wang S; Li N; Zou H; Wu M Neurosci Lett; 2019 Mar; 696():93-98. PubMed ID: 30572101 [TBL] [Abstract][Full Text] [Related]
14. Alterations of the Gut Microbiome in Hypertension. Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091 [No Abstract] [Full Text] [Related]
15. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021 [TBL] [Abstract][Full Text] [Related]
16. [The gut microbiome in Parkinson's disease]. Bedarf JR; Hildebrand F; Goeser F; Bork P; Wüllner U Nervenarzt; 2019 Feb; 90(2):160-166. PubMed ID: 30171304 [TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. Aho VTE; Pereira PAB; Voutilainen S; Paulin L; Pekkonen E; Auvinen P; Scheperjans F EBioMedicine; 2019 Jun; 44():691-707. PubMed ID: 31221587 [TBL] [Abstract][Full Text] [Related]
18. Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms. Wallen ZD; Demirkan A; Twa G; Cohen G; Dean MN; Standaert DG; Sampson TR; Payami H Nat Commun; 2022 Nov; 13(1):6958. PubMed ID: 36376318 [TBL] [Abstract][Full Text] [Related]
19. Study of the gut microbiome in Egyptian patients with Parkinson's Disease. Mehanna M; AbuRaya S; Ahmed SM; Ashmawy G; Ibrahim A; AbdelKhaliq E BMC Microbiol; 2023 Jul; 23(1):196. PubMed ID: 37481569 [TBL] [Abstract][Full Text] [Related]
20. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]